The role of gene therapy for intimal hyperplasia of bypass grafts

David G. Cable, James A. Caccitolo, Noel Caplice, Timothy O'Brien, Robert D. Simari, Richard C. Daly, Joseph A. Dearani, Charles J. Mullany, Thomas A. Orszulak, Hartzell V Schaff

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background - Proliferation of the intima is an early lesion of saphenous vein graft disease. Early patency rates of radial artery grafts are acceptable, but little is known about their risk of intimal hyperplasia. Methods and Results - To develop a model of intimal hyperplasia, we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, respectively) in an organ culture with Rosewell Park Memorial Institute 1640 (30% serum) for 0, 4, 7, 10, and 14 days. Quantitative histological studies were performed, and the average intimal-to-medial (I/M) ratio was calculated for each incubation interval. After 10 and 14 days of culture, the I/M ratio increased in the saphenous veins (P0.03, P=0.04 versus 0 day, respectively). No significant increase occurred in the I/M ratio in either the internal mammary or radial arteries. Next, the ability of adenoviral gene transfers to inhibit intimal hyperplasia in the saphenous veins was evaluated. Adenoviral-mediated gene transfer of nitric oxide synthase significantly reduced the I/M ratio at 14 days compared with vehicle (P=0.001) and virus (P=0.004) controls. Conclusions - The human saphenous vein has a greater propensity for intimal hyperplasia than arterial grafts; the human radial artery behaves similarly to the internal mammary artery. In the future, gene therapy may augment nitric oxide synthase, limiting vein graft disease.

Original languageEnglish (US)
JournalCirculation
Volume100
Issue number19 SUPPL.
StatePublished - Nov 9 1999

Fingerprint

Tunica Intima
Genetic Therapy
Hyperplasia
Saphenous Vein
Transplants
Radial Artery
Mammary Arteries
Nitric Oxide Synthase
Organ Culture Techniques
Genes
Veins
Viruses

Keywords

  • Gene transfer
  • Mammary arteries
  • Nitric oxide
  • Organ culture
  • Radial artery
  • Saphenous vein

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Cable, D. G., Caccitolo, J. A., Caplice, N., O'Brien, T., Simari, R. D., Daly, R. C., ... Schaff, H. V. (1999). The role of gene therapy for intimal hyperplasia of bypass grafts. Circulation, 100(19 SUPPL.).

The role of gene therapy for intimal hyperplasia of bypass grafts. / Cable, David G.; Caccitolo, James A.; Caplice, Noel; O'Brien, Timothy; Simari, Robert D.; Daly, Richard C.; Dearani, Joseph A.; Mullany, Charles J.; Orszulak, Thomas A.; Schaff, Hartzell V.

In: Circulation, Vol. 100, No. 19 SUPPL., 09.11.1999.

Research output: Contribution to journalArticle

Cable, DG, Caccitolo, JA, Caplice, N, O'Brien, T, Simari, RD, Daly, RC, Dearani, JA, Mullany, CJ, Orszulak, TA & Schaff, HV 1999, 'The role of gene therapy for intimal hyperplasia of bypass grafts', Circulation, vol. 100, no. 19 SUPPL..
Cable DG, Caccitolo JA, Caplice N, O'Brien T, Simari RD, Daly RC et al. The role of gene therapy for intimal hyperplasia of bypass grafts. Circulation. 1999 Nov 9;100(19 SUPPL.).
Cable, David G. ; Caccitolo, James A. ; Caplice, Noel ; O'Brien, Timothy ; Simari, Robert D. ; Daly, Richard C. ; Dearani, Joseph A. ; Mullany, Charles J. ; Orszulak, Thomas A. ; Schaff, Hartzell V. / The role of gene therapy for intimal hyperplasia of bypass grafts. In: Circulation. 1999 ; Vol. 100, No. 19 SUPPL.
@article{1d90aa29ef4348b2ad3695c769d97880,
title = "The role of gene therapy for intimal hyperplasia of bypass grafts",
abstract = "Background - Proliferation of the intima is an early lesion of saphenous vein graft disease. Early patency rates of radial artery grafts are acceptable, but little is known about their risk of intimal hyperplasia. Methods and Results - To develop a model of intimal hyperplasia, we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, respectively) in an organ culture with Rosewell Park Memorial Institute 1640 (30{\%} serum) for 0, 4, 7, 10, and 14 days. Quantitative histological studies were performed, and the average intimal-to-medial (I/M) ratio was calculated for each incubation interval. After 10 and 14 days of culture, the I/M ratio increased in the saphenous veins (P0.03, P=0.04 versus 0 day, respectively). No significant increase occurred in the I/M ratio in either the internal mammary or radial arteries. Next, the ability of adenoviral gene transfers to inhibit intimal hyperplasia in the saphenous veins was evaluated. Adenoviral-mediated gene transfer of nitric oxide synthase significantly reduced the I/M ratio at 14 days compared with vehicle (P=0.001) and virus (P=0.004) controls. Conclusions - The human saphenous vein has a greater propensity for intimal hyperplasia than arterial grafts; the human radial artery behaves similarly to the internal mammary artery. In the future, gene therapy may augment nitric oxide synthase, limiting vein graft disease.",
keywords = "Gene transfer, Mammary arteries, Nitric oxide, Organ culture, Radial artery, Saphenous vein",
author = "Cable, {David G.} and Caccitolo, {James A.} and Noel Caplice and Timothy O'Brien and Simari, {Robert D.} and Daly, {Richard C.} and Dearani, {Joseph A.} and Mullany, {Charles J.} and Orszulak, {Thomas A.} and Schaff, {Hartzell V}",
year = "1999",
month = "11",
day = "9",
language = "English (US)",
volume = "100",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "19 SUPPL.",

}

TY - JOUR

T1 - The role of gene therapy for intimal hyperplasia of bypass grafts

AU - Cable, David G.

AU - Caccitolo, James A.

AU - Caplice, Noel

AU - O'Brien, Timothy

AU - Simari, Robert D.

AU - Daly, Richard C.

AU - Dearani, Joseph A.

AU - Mullany, Charles J.

AU - Orszulak, Thomas A.

AU - Schaff, Hartzell V

PY - 1999/11/9

Y1 - 1999/11/9

N2 - Background - Proliferation of the intima is an early lesion of saphenous vein graft disease. Early patency rates of radial artery grafts are acceptable, but little is known about their risk of intimal hyperplasia. Methods and Results - To develop a model of intimal hyperplasia, we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, respectively) in an organ culture with Rosewell Park Memorial Institute 1640 (30% serum) for 0, 4, 7, 10, and 14 days. Quantitative histological studies were performed, and the average intimal-to-medial (I/M) ratio was calculated for each incubation interval. After 10 and 14 days of culture, the I/M ratio increased in the saphenous veins (P0.03, P=0.04 versus 0 day, respectively). No significant increase occurred in the I/M ratio in either the internal mammary or radial arteries. Next, the ability of adenoviral gene transfers to inhibit intimal hyperplasia in the saphenous veins was evaluated. Adenoviral-mediated gene transfer of nitric oxide synthase significantly reduced the I/M ratio at 14 days compared with vehicle (P=0.001) and virus (P=0.004) controls. Conclusions - The human saphenous vein has a greater propensity for intimal hyperplasia than arterial grafts; the human radial artery behaves similarly to the internal mammary artery. In the future, gene therapy may augment nitric oxide synthase, limiting vein graft disease.

AB - Background - Proliferation of the intima is an early lesion of saphenous vein graft disease. Early patency rates of radial artery grafts are acceptable, but little is known about their risk of intimal hyperplasia. Methods and Results - To develop a model of intimal hyperplasia, we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, respectively) in an organ culture with Rosewell Park Memorial Institute 1640 (30% serum) for 0, 4, 7, 10, and 14 days. Quantitative histological studies were performed, and the average intimal-to-medial (I/M) ratio was calculated for each incubation interval. After 10 and 14 days of culture, the I/M ratio increased in the saphenous veins (P0.03, P=0.04 versus 0 day, respectively). No significant increase occurred in the I/M ratio in either the internal mammary or radial arteries. Next, the ability of adenoviral gene transfers to inhibit intimal hyperplasia in the saphenous veins was evaluated. Adenoviral-mediated gene transfer of nitric oxide synthase significantly reduced the I/M ratio at 14 days compared with vehicle (P=0.001) and virus (P=0.004) controls. Conclusions - The human saphenous vein has a greater propensity for intimal hyperplasia than arterial grafts; the human radial artery behaves similarly to the internal mammary artery. In the future, gene therapy may augment nitric oxide synthase, limiting vein graft disease.

KW - Gene transfer

KW - Mammary arteries

KW - Nitric oxide

KW - Organ culture

KW - Radial artery

KW - Saphenous vein

UR - http://www.scopus.com/inward/record.url?scp=5444269236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444269236&partnerID=8YFLogxK

M3 - Article

C2 - 10567335

AN - SCOPUS:5444269236

VL - 100

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 19 SUPPL.

ER -